---
category: listing
circular_id: cb593bcdb13aeb19
date: '2025-12-29'
description: BSE announces listing of 7,67,407 equity shares of Vivo Bio Tech Ltd.
  issued on preferential basis pursuant to conversion of warrants, effective December
  30, 2025.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={914D13A6-6B5F-4905-800F-3349C7946BDD}&noticeno=20251229-36&dt=12/29/2025&icount=36&totcount=39&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of new securities for a single company with limited
  market-wide impact. Affects only specific shareholders of Vivo Bio Tech Ltd.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251229-36&attachedId=
processing:
  attempts: 1
  content_hash: e15ef31f0c95f92c
  processed_at: '2025-12-29T15:35:42.838225'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-29T14:07:18+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={914D13A6-6B5F-4905-800F-3349C7946BDD}&noticeno=20251229-36&dt=12/29/2025&icount=36&totcount=39&flag=0
severity: low
source: bse
stocks:
- VIVOBIOTECH
tags:
- listing
- preferential-allotment
- warrant-conversion
- equity-shares
- lock-in
title: Listing of New Securities of Vivo Bio Tech Ltd.
---

## Summary

BSE has listed 7,67,407 new equity shares of Vivo Bio Tech Ltd. (Scrip Code: 511509) issued to Non-Promoters on a preferential basis pursuant to conversion of warrants. The shares will be available for trading from December 30, 2025, and are subject to lock-in until June 30, 2026.

## Key Points

- 7,67,407 equity shares of Rs. 10/- each issued at a premium of Rs. 35/-
- Issue price: Rs. 45/- per share
- Issued to Non-Promoters on preferential basis
- Securities issued pursuant to conversion of warrants
- New shares rank pari-passu with existing equity shares
- ISIN: INE380K01017
- Distinctive Numbers: 21333222 to 22100628
- Date of Allotment: September 24, 2025

## Regulatory Changes

No regulatory changes announced. This is a routine listing notification for new securities.

## Compliance Requirements

Trading members must note:
- New securities are permitted for trading from December 30, 2025
- Lock-in restrictions apply to all 7,67,407 shares until June 30, 2026
- Trading members should update their systems to reflect the increased share capital

## Important Dates

- **Allotment Date**: September 24, 2025
- **Trading Commencement**: December 30, 2025
- **Lock-in Expiry**: June 30, 2026

## Impact Assessment

Limited impact on the broader market. This circular affects only Vivo Bio Tech Ltd. and its shareholders. The preferential allotment represents an increase in equity capital through warrant conversion. The lock-in period ensures these shares cannot be traded until June 30, 2026, limiting immediate liquidity impact. Trading members handling this scrip should be aware of the new securities and lock-in restrictions.